Skip to main content

Doug Krulik

Equibles does not estimate personal net worth.

Get an email with a short summary when Petmed Express Inc publishes a filing, an earnings call transcript or a press release.

Get PETS alerts

About Doug Krulik

Doug Krulik is recorded as CFO at Petmed Express Inc (PETS) since August 11, 2025 and Chief Accounting Officer at Petmed Express Inc (PETS) since August 19, 2024. Petmed Express Inc reported in an 8-K filed August 12, 2025 that Doug Krulik was appointed Interim Principal Financial Officer, effective August 11, 2025. Petmed Express Inc reported in an 8-K filed August 5, 2024 that Doug Krulik was appointed Chief Accounting Officer, effective August 19, 2024. Doug Krulik has spoken on 2 earnings calls across 1 company, most recently for Petmed Express Inc on August 13, 2026. Petmed Express Inc is classified in the Pharmaceutical Retailers industry within the Healthcare sector. Other leadership on record at Petmed Express Inc includes Bruce S. Rosenbloom (CEO), Jeff Willard (CEO and Board Member), Jeffrey Allen Willard (CEO and Board Member) and 7 others.

“On and effective as of August 11, 2025, the Board appointed Doug Krulik, the Chief Accounting Officer of the Company, to serve as the Interim Principal Financial Officer of the Company.”
Petmed Express Inc Form 8-K, filed August 12, 2025 · Read the filing
“On August 2, 2024, the Board of Directors of PetMed Express, Inc. ("Company") appointed Doug Krulik to serve as the Company's Chief Accounting Officer to assume the duties of principal accounting officer and interim-principal financial officer effective August 19, 2024 ("Effective Date").”
Petmed Express Inc Form 8-K, filed August 5, 2024 · Read the filing

Doug Krulik on recent calls

“Net sales for the first quarter were $41 million compared to $51.2 million in the same period last year, representing a third consecutive quarter of revenue stabilization above $40 million, although a 19.9% year-over-year decline, primarily driven by decline in prescription medication sales, partially offset by lower…”
Chief Accounting Officer, PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026 ·
“Net sales for the fourth quarter were $42.8 million compared to $50.8 million in the same period last year, a 15.6% decline, primarily driven by a decline in prescription medication sales.”
Chief Accounting Officer, Petmed Express Inc Q4 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Petmed Express Inc

Recent activity